drugset / Trial / NCT00689806

Evaluation of Lovastatin in Severe Persistent Asthma

NCT00689806

Phase 1/2 Withdrawn University of Chicago
RandomizedParallel-groupTriple-blindTreatment

Summary

This study has two purposes: 1. to determine whether lovastatin, a commonly used medication to lower cholesterol in the blood, can produce beneficial changes in airway inflammation and in the airway smooth muscle 2. to examine whether lovastatin will have favorable changes in asthma symptoms of patients with moderate or severe asthma.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lovastatin Small molecule 60 mg Oral

Indications